AU2020904824A0 - Treatment for Coronavirus infection and associated cytokine toxicity (2) - Google Patents

Treatment for Coronavirus infection and associated cytokine toxicity (2)

Info

Publication number
AU2020904824A0
AU2020904824A0 AU2020904824A AU2020904824A AU2020904824A0 AU 2020904824 A0 AU2020904824 A0 AU 2020904824A0 AU 2020904824 A AU2020904824 A AU 2020904824A AU 2020904824 A AU2020904824 A AU 2020904824A AU 2020904824 A0 AU2020904824 A0 AU 2020904824A0
Authority
AU
Australia
Prior art keywords
treatment
coronavirus infection
associated cytokine
cytokine toxicity
toxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020904824A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2020904824A0 publication Critical patent/AU2020904824A0/en
Priority to US17/910,220 priority Critical patent/US20230120864A1/en
Priority to AU2021234945A priority patent/AU2021234945A1/en
Priority to EP21767048.8A priority patent/EP4117683A4/en
Priority to PCT/AU2021/050215 priority patent/WO2021179047A1/en
Priority to BR112022018200A priority patent/BR112022018200A2/en
Priority to CN202180031179.5A priority patent/CN115484964B/en
Priority to JP2022554820A priority patent/JP2023517239A/en
Priority to CA3171235A priority patent/CA3171235A1/en
Priority to KR1020227035531A priority patent/KR20220159397A/en
Priority to CL2022002457A priority patent/CL2022002457A1/en
Priority to US18/071,800 priority patent/US11938146B2/en
Abandoned legal-status Critical Current

Links

AU2020904824A 2020-03-12 2020-12-23 Treatment for Coronavirus infection and associated cytokine toxicity (2) Abandoned AU2020904824A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
KR1020227035531A KR20220159397A (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and related cytokine toxicity
BR112022018200A BR112022018200A2 (en) 2020-03-12 2021-03-12 TREATMENT FOR CORONAVIRUS INFECTION AND ASSOCIATED CYTOKINE TOXICITY
AU2021234945A AU2021234945A1 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
EP21767048.8A EP4117683A4 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
PCT/AU2021/050215 WO2021179047A1 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
US17/910,220 US20230120864A1 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
CN202180031179.5A CN115484964B (en) 2020-03-12 2021-03-12 Treatment of coronavirus infection and associated cytokine toxicity
JP2022554820A JP2023517239A (en) 2020-03-12 2021-03-12 Treatment of coronavirus infection and associated cytokine toxicity
CA3171235A CA3171235A1 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
CL2022002457A CL2022002457A1 (en) 2020-03-12 2022-09-08 Treatment of coronavirus infection and cytokine-associated toxicity
US18/071,800 US11938146B2 (en) 2020-03-12 2022-11-30 Treatment for coronavirus infection and associated cytokine toxicity

Publications (1)

Publication Number Publication Date
AU2020904824A0 true AU2020904824A0 (en) 2021-01-21

Family

ID=

Similar Documents

Publication Publication Date Title
WO2021188969A3 (en) Coronavirus vaccines and methods of use
EP4118115A4 (en) Methods for treating coronavirus infection and resulting inflammation-induced lung injury
UA88463C2 (en) Pharmaceutical composition comprising compound i and method of treating hiv infection
WO2005000878A8 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
EP4121022A4 (en) Compositions and methods for treating and preventing a coronavirus infection
EP4093758A4 (en) Methods and compositions for treating and preventing viral infection
IL277315B (en) Methods and composition for treating coronavirus infection
WO2022053993A3 (en) Treatments for sars-cov-2 infection (covid-19)
AU2020904824A0 (en) Treatment for Coronavirus infection and associated cytokine toxicity (2)
EP4074310A4 (en) Drug for treating coronaviral and retroviral infections and hepatitis c
EP4121084A4 (en) Compositions for treating respiratory tract infection and uses thereof
EP4101452A4 (en) Use of 4-aminoquinoline compound in treatment of coronavirus infection
EP4117683A4 (en) Treatment for coronavirus infection and associated cytokine toxicity
AU2020900751A0 (en) Treatment for coronavirus infection and associated cytokine toxicity
EP4121038A4 (en) Compositions and methods for the treatment of coronavirus infection and respiratory compromise
WO2023122260A3 (en) Inhibitors of sars-cov-2
EP4164619A4 (en) Treatment methods and formulations
EP4103192A4 (en) Compositions and methods for treating coronavirus infections
EP4223303A4 (en) Antiviral agent for preventing or treating covid-19 infection
MX2023008004A (en) Adenosine derivative and pharmaceutical composition comprising the same.
EP4146240A4 (en) Methods of treating or preventing coronavirus infection
EP4140479A4 (en) Therapeutic and/or preventive agent for coronavirus disease 2019 (covid-19)
EP4153609A4 (en) Compositions and methods for prevention of coronavirus infection
AU2020902150A0 (en) Coronavirus treatment (2)
AU2020902151A0 (en) Treatment of coronavirus (2)